Muenzer J - Search Results

1

A phase II/III clinical study of enzyme replacement therapy with idursulfase in mucopolysaccharidosis II (Hunter syndrome).

Muenzer J, Wraith JE, Beck M, Giugliani R, Harmatz P, Eng CM, Vellodi A, Martin R, Ramaswami U, Gucsavas-Calikoglu M, Vijayaraghavan S, Wendt S, Puga AC, Ulbrich B, Shinawi M, Cleary M, Piper D, Conway AM, Kimura A. Muenzer J, et al. Genet Med. 2006 Aug;8(8):465-73. doi: 10.1097/01.gim.0000232477.37660.fb. Genet Med. 2006. PMID: 16912578 Free article. Clinical Trial.

2

Enzyme-replacement therapy in mucopolysaccharidosis I.

Kakkis ED, Muenzer J, Tiller GE, Waber L, Belmont J, Passage M, Izykowski B, Phillips J, Doroshow R, Walot I, Hoft R, Neufeld EF. Kakkis ED, et al. Among authors: muenzer j. N Engl J Med. 2001 Jan 18;344(3):182-8. doi: 10.1056/NEJM200101183440304. N Engl J Med. 2001. PMID: 11172140 Free article. Clinical Trial.

3

Enzyme replacement therapy in mucopolysaccharidosis type II (Hunter syndrome): a preliminary report.

Muenzer J, Lamsa JC, Garcia A, Dacosta J, Garcia J, Treco DA. Muenzer J, et al. Acta Paediatr Suppl. 2002;91(439):98-9. doi: 10.1111/j.1651-2227.2002.tb03115.x. Acta Paediatr Suppl. 2002. PMID: 12572850 Review.

4

Enzyme replacement therapy for mucopolysaccharidosis I: a randomized, double-blinded, placebo-controlled, multinational study of recombinant human alpha-L-iduronidase (laronidase).

Wraith JE, Clarke LA, Beck M, Kolodny EH, Pastores GM, Muenzer J, Rapoport DM, Berger KI, Swiedler SJ, Kakkis ED, Braakman T, Chadbourne E, Walton-Bowen K, Cox GF. Wraith JE, et al. Among authors: muenzer j. J Pediatr. 2004 May;144(5):581-8. doi: 10.1016/j.jpeds.2004.01.046. J Pediatr. 2004. PMID: 15126990 Clinical Trial.

5

A phase I/II clinical trial of enzyme replacement therapy in mucopolysaccharidosis II (Hunter syndrome).

Muenzer J, Gucsavas-Calikoglu M, McCandless SE, Schuetz TJ, Kimura A. Muenzer J, et al. Mol Genet Metab. 2007 Mar;90(3):329-37. doi: 10.1016/j.ymgme.2006.09.001. Epub 2006 Dec 20. Mol Genet Metab. 2007. PMID: 17185020 Clinical Trial.

6

The MPS I registry: design, methodology, and early findings of a global disease registry for monitoring patients with Mucopolysaccharidosis Type I.

Pastores GM, Arn P, Beck M, Clarke JT, Guffon N, Kaplan P, Muenzer J, Norato DY, Shapiro E, Thomas J, Viskochil D, Wraith JE. Pastores GM, et al. Among authors: muenzer j. Mol Genet Metab. 2007 May;91(1):37-47. doi: 10.1016/j.ymgme.2007.01.011. Epub 2007 Mar 2. Mol Genet Metab. 2007. PMID: 17336562

7

Preclinical dose ranging studies for enzyme replacement therapy with idursulfase in a knock-out mouse model of MPS II.

Garcia AR, DaCosta JM, Pan J, Muenzer J, Lamsa JC. Garcia AR, et al. Among authors: muenzer j. Mol Genet Metab. 2007 Jun;91(2):183-90. doi: 10.1016/j.ymgme.2007.03.003. Epub 2007 Apr 24. Mol Genet Metab. 2007. PMID: 17459751

8

Recognition and diagnosis of mucopolysaccharidosis II (Hunter syndrome).

Martin R, Beck M, Eng C, Giugliani R, Harmatz P, Muñoz V, Muenzer J. Martin R, et al. Among authors: muenzer j. Pediatrics. 2008 Feb;121(2):e377-86. doi: 10.1542/peds.2007-1350. Pediatrics. 2008. PMID: 18245410 Review.

9

Hunter syndrome: to treat or not to treat.

Muenzer J, Martins AM. Muenzer J, et al. Acta Paediatr. 2008 Apr;97(457):55-6. doi: 10.1111/j.1651-2227.2008.00644.x. Acta Paediatr. 2008. PMID: 18339189 No abstract available.

10

Initial report from the Hunter Outcome Survey.

Wraith JE, Beck M, Giugliani R, Clarke J, Martin R, Muenzer J; HOS Investigators. Wraith JE, et al. Among authors: muenzer j. Genet Med. 2008 Jul;10(7):508-16. doi: 10.1097/gim.0b013e31817701e6. Genet Med. 2008. PMID: 18580692

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

155 results

Search Page